vaccine virus vac number immune eva strategy include multiple meghan inhibit interferon regulatory factor irf nuclear κb nfκb type in signal use highly multiplex proteam quantify cellular protein viral seven time point throughout infect total downregul fold put natur killer cell ligand ifnstimul gene twothird target class ii piston deacetylas dac degrade proteolyt followup analysis demons restrict replica her simplex genre proteins tempo classis gene express identify protein c multifunct antagonist necessary suffice proteasome degrade approach thu identify host antivirus meghan innate 